Daldegan-Bueno D
School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand. Electronic address: d.daldegan@auckland.ac.nz.
ArticleLSD
LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.
ArticleLSD
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial.
ArticleLSD
LSD microdosing in major depressive disorder: results from an open-label trial.
ArticleLSD
Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.
ArticleAyahuasca
OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study.
ArticleLSD
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.
ArticleLSD
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).
ArticleAyahuasca
The current state of ayahuasca research in animal models: A systematic review.
ArticleLSD
LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals.
ArticleAyahuasca
Ayahuasca's therapeutic potential: What we know - and what not.
PreprintAyahuasca
The current state of ayahuasca research in animal models: A systematic review
ArticlePsychedelics
Systematic Review of Psychometric Instruments Used in Research with Psychedelics.
ArticleLSD